Global Glyburide Market Growth 2023-2029

February 2023 | 116 pages | ID: G3273975E1E0EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Glyburide is a second generation sulfonylurea used to treat patients with diabetes mellitus type II. It is typically given to patients who cannot be managed with the standard first line therapy, metformin. Glyburide stimulates insulin secretion through the closure of ATP-sensitive potassium channels on beta cells, raising intracellular potassium and calcium ion concentrations.

LPI (LP Information)' newest research report, the “Glyburide Industry Forecast” looks at past sales and reviews total world Glyburide sales in 2022, providing a comprehensive analysis by region and market sector of projected Glyburide sales for 2023 through 2029. With Glyburide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glyburide industry.

This Insight Report provides a comprehensive analysis of the global Glyburide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glyburide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Glyburide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glyburide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glyburide.

The global Glyburide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Glyburide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Glyburide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Glyburide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Glyburide players cover Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, Bohai Pharmaceutical, Sunlight Pharmaceutical, Shapuaisi Pharma, CR Sanjiu and Physicians Total Care, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Glyburide market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • 1.25mg
  • 2.5mg
  • 5mg
Segmentation by application
  • Pediatric Use
  • Geriatric Use
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Amneal Pharmaceuticals
  • Sanofi Aventis
  • Jisheng Medicine
  • Double Whale Pharmaceutical
  • Bohai Pharmaceutical
  • Sunlight Pharmaceutical
  • Shapuaisi Pharma
  • CR Sanjiu
  • Physicians Total Care
  • Hoechst Canada
  • Apotex Corporation
  • Avanstra
  • Dominion Pharmacal
  • Hikma Pharmaceuticals
  • Cadila Pharmaceuticals
  • Novartis
Key Questions Addressed in this Report

What is the 10-year outlook for the global Glyburide market?

What factors are driving Glyburide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glyburide market opportunities vary by end market size?

How does Glyburide break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Glyburide Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Glyburide by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Glyburide by Country/Region, 2018, 2022 & 2029
2.2 Glyburide Segment by Type
  2.2.1 1.25mg
  2.2.2 2.5mg
  2.2.3 5mg
2.3 Glyburide Sales by Type
  2.3.1 Global Glyburide Sales Market Share by Type (2018-2023)
  2.3.2 Global Glyburide Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Glyburide Sale Price by Type (2018-2023)
2.4 Glyburide Segment by Application
  2.4.1 Pediatric Use
  2.4.2 Geriatric Use
  2.4.3 Others
2.5 Glyburide Sales by Application
  2.5.1 Global Glyburide Sale Market Share by Application (2018-2023)
  2.5.2 Global Glyburide Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Glyburide Sale Price by Application (2018-2023)

3 GLOBAL GLYBURIDE BY COMPANY

3.1 Global Glyburide Breakdown Data by Company
  3.1.1 Global Glyburide Annual Sales by Company (2018-2023)
  3.1.2 Global Glyburide Sales Market Share by Company (2018-2023)
3.2 Global Glyburide Annual Revenue by Company (2018-2023)
  3.2.1 Global Glyburide Revenue by Company (2018-2023)
  3.2.2 Global Glyburide Revenue Market Share by Company (2018-2023)
3.3 Global Glyburide Sale Price by Company
3.4 Key Manufacturers Glyburide Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Glyburide Product Location Distribution
  3.4.2 Players Glyburide Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR GLYBURIDE BY GEOGRAPHIC REGION

4.1 World Historic Glyburide Market Size by Geographic Region (2018-2023)
  4.1.1 Global Glyburide Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Glyburide Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Glyburide Market Size by Country/Region (2018-2023)
  4.2.1 Global Glyburide Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Glyburide Annual Revenue by Country/Region (2018-2023)
4.3 Americas Glyburide Sales Growth
4.4 APAC Glyburide Sales Growth
4.5 Europe Glyburide Sales Growth
4.6 Middle East & Africa Glyburide Sales Growth

5 AMERICAS

5.1 Americas Glyburide Sales by Country
  5.1.1 Americas Glyburide Sales by Country (2018-2023)
  5.1.2 Americas Glyburide Revenue by Country (2018-2023)
5.2 Americas Glyburide Sales by Type
5.3 Americas Glyburide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Glyburide Sales by Region
  6.1.1 APAC Glyburide Sales by Region (2018-2023)
  6.1.2 APAC Glyburide Revenue by Region (2018-2023)
6.2 APAC Glyburide Sales by Type
6.3 APAC Glyburide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Glyburide by Country
  7.1.1 Europe Glyburide Sales by Country (2018-2023)
  7.1.2 Europe Glyburide Revenue by Country (2018-2023)
7.2 Europe Glyburide Sales by Type
7.3 Europe Glyburide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Glyburide by Country
  8.1.1 Middle East & Africa Glyburide Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Glyburide Revenue by Country (2018-2023)
8.2 Middle East & Africa Glyburide Sales by Type
8.3 Middle East & Africa Glyburide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glyburide
10.3 Manufacturing Process Analysis of Glyburide
10.4 Industry Chain Structure of Glyburide

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Glyburide Distributors
11.3 Glyburide Customer

12 WORLD FORECAST REVIEW FOR GLYBURIDE BY GEOGRAPHIC REGION

12.1 Global Glyburide Market Size Forecast by Region
  12.1.1 Global Glyburide Forecast by Region (2024-2029)
  12.1.2 Global Glyburide Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glyburide Forecast by Type
12.7 Global Glyburide Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Amneal Pharmaceuticals
  13.1.1 Amneal Pharmaceuticals Company Information
  13.1.2 Amneal Pharmaceuticals Glyburide Product Portfolios and Specifications
  13.1.3 Amneal Pharmaceuticals Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Amneal Pharmaceuticals Main Business Overview
  13.1.5 Amneal Pharmaceuticals Latest Developments
13.2 Sanofi Aventis
  13.2.1 Sanofi Aventis Company Information
  13.2.2 Sanofi Aventis Glyburide Product Portfolios and Specifications
  13.2.3 Sanofi Aventis Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Sanofi Aventis Main Business Overview
  13.2.5 Sanofi Aventis Latest Developments
13.3 Jisheng Medicine
  13.3.1 Jisheng Medicine Company Information
  13.3.2 Jisheng Medicine Glyburide Product Portfolios and Specifications
  13.3.3 Jisheng Medicine Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Jisheng Medicine Main Business Overview
  13.3.5 Jisheng Medicine Latest Developments
13.4 Double Whale Pharmaceutical
  13.4.1 Double Whale Pharmaceutical Company Information
  13.4.2 Double Whale Pharmaceutical Glyburide Product Portfolios and Specifications
  13.4.3 Double Whale Pharmaceutical Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Double Whale Pharmaceutical Main Business Overview
  13.4.5 Double Whale Pharmaceutical Latest Developments
13.5 Bohai Pharmaceutical
  13.5.1 Bohai Pharmaceutical Company Information
  13.5.2 Bohai Pharmaceutical Glyburide Product Portfolios and Specifications
  13.5.3 Bohai Pharmaceutical Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Bohai Pharmaceutical Main Business Overview
  13.5.5 Bohai Pharmaceutical Latest Developments
13.6 Sunlight Pharmaceutical
  13.6.1 Sunlight Pharmaceutical Company Information
  13.6.2 Sunlight Pharmaceutical Glyburide Product Portfolios and Specifications
  13.6.3 Sunlight Pharmaceutical Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Sunlight Pharmaceutical Main Business Overview
  13.6.5 Sunlight Pharmaceutical Latest Developments
13.7 Shapuaisi Pharma
  13.7.1 Shapuaisi Pharma Company Information
  13.7.2 Shapuaisi Pharma Glyburide Product Portfolios and Specifications
  13.7.3 Shapuaisi Pharma Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Shapuaisi Pharma Main Business Overview
  13.7.5 Shapuaisi Pharma Latest Developments
13.8 CR Sanjiu
  13.8.1 CR Sanjiu Company Information
  13.8.2 CR Sanjiu Glyburide Product Portfolios and Specifications
  13.8.3 CR Sanjiu Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 CR Sanjiu Main Business Overview
  13.8.5 CR Sanjiu Latest Developments
13.9 Physicians Total Care
  13.9.1 Physicians Total Care Company Information
  13.9.2 Physicians Total Care Glyburide Product Portfolios and Specifications
  13.9.3 Physicians Total Care Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Physicians Total Care Main Business Overview
  13.9.5 Physicians Total Care Latest Developments
13.10 Hoechst Canada
  13.10.1 Hoechst Canada Company Information
  13.10.2 Hoechst Canada Glyburide Product Portfolios and Specifications
  13.10.3 Hoechst Canada Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Hoechst Canada Main Business Overview
  13.10.5 Hoechst Canada Latest Developments
13.11 Apotex Corporation
  13.11.1 Apotex Corporation Company Information
  13.11.2 Apotex Corporation Glyburide Product Portfolios and Specifications
  13.11.3 Apotex Corporation Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Apotex Corporation Main Business Overview
  13.11.5 Apotex Corporation Latest Developments
13.12 Avanstra
  13.12.1 Avanstra Company Information
  13.12.2 Avanstra Glyburide Product Portfolios and Specifications
  13.12.3 Avanstra Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Avanstra Main Business Overview
  13.12.5 Avanstra Latest Developments
13.13 Dominion Pharmacal
  13.13.1 Dominion Pharmacal Company Information
  13.13.2 Dominion Pharmacal Glyburide Product Portfolios and Specifications
  13.13.3 Dominion Pharmacal Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Dominion Pharmacal Main Business Overview
  13.13.5 Dominion Pharmacal Latest Developments
13.14 Hikma Pharmaceuticals
  13.14.1 Hikma Pharmaceuticals Company Information
  13.14.2 Hikma Pharmaceuticals Glyburide Product Portfolios and Specifications
  13.14.3 Hikma Pharmaceuticals Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Hikma Pharmaceuticals Main Business Overview
  13.14.5 Hikma Pharmaceuticals Latest Developments
13.15 Cadila Pharmaceuticals
  13.15.1 Cadila Pharmaceuticals Company Information
  13.15.2 Cadila Pharmaceuticals Glyburide Product Portfolios and Specifications
  13.15.3 Cadila Pharmaceuticals Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Cadila Pharmaceuticals Main Business Overview
  13.15.5 Cadila Pharmaceuticals Latest Developments
13.16 Novartis
  13.16.1 Novartis Company Information
  13.16.2 Novartis Glyburide Product Portfolios and Specifications
  13.16.3 Novartis Glyburide Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Novartis Main Business Overview
  13.16.5 Novartis Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Glyburide Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Glyburide Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 1.25mg
Table 4. Major Players of 2.5mg
Table 5. Major Players of 5mg
Table 6. Global Glyburide Sales by Type (2018-2023) & (K Units)
Table 7. Global Glyburide Sales Market Share by Type (2018-2023)
Table 8. Global Glyburide Revenue by Type (2018-2023) & ($ million)
Table 9. Global Glyburide Revenue Market Share by Type (2018-2023)
Table 10. Global Glyburide Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Glyburide Sales by Application (2018-2023) & (K Units)
Table 12. Global Glyburide Sales Market Share by Application (2018-2023)
Table 13. Global Glyburide Revenue by Application (2018-2023)
Table 14. Global Glyburide Revenue Market Share by Application (2018-2023)
Table 15. Global Glyburide Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Glyburide Sales by Company (2018-2023) & (K Units)
Table 17. Global Glyburide Sales Market Share by Company (2018-2023)
Table 18. Global Glyburide Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Glyburide Revenue Market Share by Company (2018-2023)
Table 20. Global Glyburide Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Glyburide Producing Area Distribution and Sales Area
Table 22. Players Glyburide Products Offered
Table 23. Glyburide Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Glyburide Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Glyburide Sales Market Share Geographic Region (2018-2023)
Table 28. Global Glyburide Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Glyburide Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Glyburide Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Glyburide Sales Market Share by Country/Region (2018-2023)
Table 32. Global Glyburide Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Glyburide Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Glyburide Sales by Country (2018-2023) & (K Units)
Table 35. Americas Glyburide Sales Market Share by Country (2018-2023)
Table 36. Americas Glyburide Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Glyburide Revenue Market Share by Country (2018-2023)
Table 38. Americas Glyburide Sales by Type (2018-2023) & (K Units)
Table 39. Americas Glyburide Sales by Application (2018-2023) & (K Units)
Table 40. APAC Glyburide Sales by Region (2018-2023) & (K Units)
Table 41. APAC Glyburide Sales Market Share by Region (2018-2023)
Table 42. APAC Glyburide Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Glyburide Revenue Market Share by Region (2018-2023)
Table 44. APAC Glyburide Sales by Type (2018-2023) & (K Units)
Table 45. APAC Glyburide Sales by Application (2018-2023) & (K Units)
Table 46. Europe Glyburide Sales by Country (2018-2023) & (K Units)
Table 47. Europe Glyburide Sales Market Share by Country (2018-2023)
Table 48. Europe Glyburide Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Glyburide Revenue Market Share by Country (2018-2023)
Table 50. Europe Glyburide Sales by Type (2018-2023) & (K Units)
Table 51. Europe Glyburide Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Glyburide Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Glyburide Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Glyburide Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Glyburide Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Glyburide Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Glyburide Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Glyburide
Table 59. Key Market Challenges & Risks of Glyburide
Table 60. Key Industry Trends of Glyburide
Table 61. Glyburide Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Glyburide Distributors List
Table 64. Glyburide Customer List
Table 65. Global Glyburide Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Glyburide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Glyburide Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Glyburide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Glyburide Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Glyburide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Glyburide Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Glyburide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Glyburide Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Glyburide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Glyburide Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Glyburide Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Glyburide Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Glyburide Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Amneal Pharmaceuticals Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 80. Amneal Pharmaceuticals Glyburide Product Portfolios and Specifications
Table 81. Amneal Pharmaceuticals Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Amneal Pharmaceuticals Main Business
Table 83. Amneal Pharmaceuticals Latest Developments
Table 84. Sanofi Aventis Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Aventis Glyburide Product Portfolios and Specifications
Table 86. Sanofi Aventis Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Sanofi Aventis Main Business
Table 88. Sanofi Aventis Latest Developments
Table 89. Jisheng Medicine Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 90. Jisheng Medicine Glyburide Product Portfolios and Specifications
Table 91. Jisheng Medicine Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Jisheng Medicine Main Business
Table 93. Jisheng Medicine Latest Developments
Table 94. Double Whale Pharmaceutical Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 95. Double Whale Pharmaceutical Glyburide Product Portfolios and Specifications
Table 96. Double Whale Pharmaceutical Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Double Whale Pharmaceutical Main Business
Table 98. Double Whale Pharmaceutical Latest Developments
Table 99. Bohai Pharmaceutical Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 100. Bohai Pharmaceutical Glyburide Product Portfolios and Specifications
Table 101. Bohai Pharmaceutical Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Bohai Pharmaceutical Main Business
Table 103. Bohai Pharmaceutical Latest Developments
Table 104. Sunlight Pharmaceutical Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 105. Sunlight Pharmaceutical Glyburide Product Portfolios and Specifications
Table 106. Sunlight Pharmaceutical Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Sunlight Pharmaceutical Main Business
Table 108. Sunlight Pharmaceutical Latest Developments
Table 109. Shapuaisi Pharma Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 110. Shapuaisi Pharma Glyburide Product Portfolios and Specifications
Table 111. Shapuaisi Pharma Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Shapuaisi Pharma Main Business
Table 113. Shapuaisi Pharma Latest Developments
Table 114. CR Sanjiu Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 115. CR Sanjiu Glyburide Product Portfolios and Specifications
Table 116. CR Sanjiu Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. CR Sanjiu Main Business
Table 118. CR Sanjiu Latest Developments
Table 119. Physicians Total Care Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 120. Physicians Total Care Glyburide Product Portfolios and Specifications
Table 121. Physicians Total Care Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Physicians Total Care Main Business
Table 123. Physicians Total Care Latest Developments
Table 124. Hoechst Canada Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 125. Hoechst Canada Glyburide Product Portfolios and Specifications
Table 126. Hoechst Canada Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Hoechst Canada Main Business
Table 128. Hoechst Canada Latest Developments
Table 129. Apotex Corporation Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 130. Apotex Corporation Glyburide Product Portfolios and Specifications
Table 131. Apotex Corporation Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Apotex Corporation Main Business
Table 133. Apotex Corporation Latest Developments
Table 134. Avanstra Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 135. Avanstra Glyburide Product Portfolios and Specifications
Table 136. Avanstra Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Avanstra Main Business
Table 138. Avanstra Latest Developments
Table 139. Dominion Pharmacal Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 140. Dominion Pharmacal Glyburide Product Portfolios and Specifications
Table 141. Dominion Pharmacal Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Dominion Pharmacal Main Business
Table 143. Dominion Pharmacal Latest Developments
Table 144. Hikma Pharmaceuticals Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 145. Hikma Pharmaceuticals Glyburide Product Portfolios and Specifications
Table 146. Hikma Pharmaceuticals Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Hikma Pharmaceuticals Main Business
Table 148. Hikma Pharmaceuticals Latest Developments
Table 149. Cadila Pharmaceuticals Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 150. Cadila Pharmaceuticals Glyburide Product Portfolios and Specifications
Table 151. Cadila Pharmaceuticals Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Cadila Pharmaceuticals Main Business
Table 153. Cadila Pharmaceuticals Latest Developments
Table 154. Novartis Basic Information, Glyburide Manufacturing Base, Sales Area and Its Competitors
Table 155. Novartis Glyburide Product Portfolios and Specifications
Table 156. Novartis Glyburide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Novartis Main Business
Table 158. Novartis Latest Developments

LIST OF FIGURES

Figure 1. Picture of Glyburide
Figure 2. Glyburide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glyburide Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Glyburide Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Glyburide Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 1.25mg
Figure 10. Product Picture of 2.5mg
Figure 11. Product Picture of 5mg
Figure 12. Global Glyburide Sales Market Share by Type in 2022
Figure 13. Global Glyburide Revenue Market Share by Type (2018-2023)
Figure 14. Glyburide Consumed in Pediatric Use
Figure 15. Global Glyburide Market: Pediatric Use (2018-2023) & (K Units)
Figure 16. Glyburide Consumed in Geriatric Use
Figure 17. Global Glyburide Market: Geriatric Use (2018-2023) & (K Units)
Figure 18. Glyburide Consumed in Others
Figure 19. Global Glyburide Market: Others (2018-2023) & (K Units)
Figure 20. Global Glyburide Sales Market Share by Application (2022)
Figure 21. Global Glyburide Revenue Market Share by Application in 2022
Figure 22. Glyburide Sales Market by Company in 2022 (K Units)
Figure 23. Global Glyburide Sales Market Share by Company in 2022
Figure 24. Glyburide Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Glyburide Revenue Market Share by Company in 2022
Figure 26. Global Glyburide Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Glyburide Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Glyburide Sales 2018-2023 (K Units)
Figure 29. Americas Glyburide Revenue 2018-2023 ($ Millions)
Figure 30. APAC Glyburide Sales 2018-2023 (K Units)
Figure 31. APAC Glyburide Revenue 2018-2023 ($ Millions)
Figure 32. Europe Glyburide Sales 2018-2023 (K Units)
Figure 33. Europe Glyburide Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Glyburide Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Glyburide Revenue 2018-2023 ($ Millions)
Figure 36. Americas Glyburide Sales Market Share by Country in 2022
Figure 37. Americas Glyburide Revenue Market Share by Country in 2022
Figure 38. Americas Glyburide Sales Market Share by Type (2018-2023)
Figure 39. Americas Glyburide Sales Market Share by Application (2018-2023)
Figure 40. United States Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Glyburide Sales Market Share by Region in 2022
Figure 45. APAC Glyburide Revenue Market Share by Regions in 2022
Figure 46. APAC Glyburide Sales Market Share by Type (2018-2023)
Figure 47. APAC Glyburide Sales Market Share by Application (2018-2023)
Figure 48. China Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Glyburide Sales Market Share by Country in 2022
Figure 56. Europe Glyburide Revenue Market Share by Country in 2022
Figure 57. Europe Glyburide Sales Market Share by Type (2018-2023)
Figure 58. Europe Glyburide Sales Market Share by Application (2018-2023)
Figure 59. Germany Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Glyburide Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Glyburide Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Glyburide Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Glyburide Sales Market Share by Application (2018-2023)
Figure 68. Egypt Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Glyburide Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Glyburide in 2022
Figure 74. Manufacturing Process Analysis of Glyburide
Figure 75. Industry Chain Structure of Glyburide
Figure 76. Channels of Distribution
Figure 77. Global Glyburide Sales Market Forecast by Region (2024-2029)
Figure 78. Global Glyburide Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Glyburide Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Glyburide Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Glyburide Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Glyburide Revenue Market Share Forecast by Application (2024-2029)


More Publications

Global Warming Blanket Market Growth 2024-2030 US$ 3,660.00 December 2024 106 pages
Global Cell Culturing Devices Market Growth 2023-2029 US$ 3,660.00 March 2023 102 pages